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monomethyl arginine), a specific inhibitor of NO synthesis, was studied on
the coronary vascular effects of SP The specificity of L-NMMA was tested us-
ing the endothelium-independent dilator, sodium nitroprusside (SNP). Fifteen
pts with angiographically normal epicardial coronary arteries «20% steno-
sis) had intracoronary SP (5,10,20 pmol/min) and SNP (40 ~g/min) given be-
fore and after L-NMMA (64 ~mollmin). Coronary blood flow was measured
by Doppler flow wire and diameter by quantitative angiography.
Results: At baseline, a peak 17 ± 18% (mean ± SO, P < 0.01) increase
in distal coronary artery diameter, and a 20 ± 18% (p < 0.01) decrease in
coronary vascular resistance (CVR) indicated epicardial and microvascular
dilation with SP At rest, L-NMMA caused a 22 ± 27% increase in CVR and
a 13 ± 13% reduction in CA diameter, indicating tonic basal release of NO
from coronary epicardial and microvessels. L-NMMA also suppressed the
dilatory effects of SP (p < 0.01): after L-NMMA, SP produced an insignifi-
cant change in diameter 1+1 ± 15%) and CVR was 42% higher compared to
control. SNP produced a 19 ± 17% increase in epicardial CA diameter and
a 55 ± 20% reduction in CVR at baseline that was not significantly altered
by L-NMMA, suggesting that the effects of L-NMMA on the responses to SP
are specifically due to inhibition of NO production.
Conclusion: Human coronary epicardial and microvascular dilation with SP
is due, at least partly, to release of NO. Disease-induced differences in re-
sponses to endothelium-dependent dilators may be explained by a variation
in the extent to which specific receptors on the endothelial surface are af-
fected by pathologic conditions.
Endothelin (ET) is an endothelium-derived vasoactive peptide, its possible
contribution to myocardial ischemia and infarction is not yet well understood.
Aim of the study was to elucidate whether a brief period of myocardial
ischemia (CI) not leading to myocardial infarction may increase plasma ET
levels and to determine the kinetics of a possible ET release.
A coronary sinus lactate study with incremental atrial pacing was per-
formed in 16 patients (pts) with obstructive coronary artery multivessel dis-
ease (CAD). A Zucker-catheter was positioned in the distal coronary sinus
for incremental atrial pacing (100-160 bpm) and lactate sampling, ET was
measured by a radio-immuno-assay 1100% ET-1, 52% ET-2, 96% ET-3, 7%
Big-ET, Nichols Institute). ET, cardiac troponin-T (TnT, Boehringer Mannheim)
and creatine phosphokinase (CPK) samples were withdrawn from the coro-
nary sinus (CS) and a peripheral vein (PV) before and at time 1, 5, 10,30, 45
min, 1, 2, 3, 6 h after pacing. Significant ST depressions in the 12-lead ECG
after pacing was a further criterion for CI. A comparison to the results of a
control group (CG, n = 13) without heart disease and statistical analysis was
done.
Results: In CAD pacing stress induced a CI in all pts (duration 6.1 ± 1.2
min). The mean cardiac lactate production was 143.9 ± 19.3% compared
with the arterial lactate concentration, all pts suffered from typical angina
pectoris, significant ST depressions of 0.32 ± 0.11 mV were found in 14/16
pts. All pts developed pathological elevated ET concentration, whereas the
levels in the CG were within the limits of normal (p < 0.003). The mean ET
concentrations increased from 5.0 pg/ml in CS and PV before pacing to 10.9
pg/ml in CS and 8.9 pg/ml in PV at 1 min after the end of pacing. The concen-
trations further remained elevated within 1 h after pacing with higher levels
in CS than in PV due to a persisting cardiac release of ET, ET concentrations
dropped to the limits of normal (2.3-5.3 pg/ml) after 1 h with identical levels
in CS and PV In both groups TnT and CPK were not elevated, no signs of CI
were detected in the CG
Conclusions: A short lasting severe myocardial ischemia without myocar-
dial infarction was followed by a significant ET release for 1 h reaching 218%
of the base line concentration in CS and 178% in PV respectively. The higher
ET levels in CS compared to PV indicate, that the ET release is of cardiac
origin.
Contribution of Nitric Oxide to Post-Ischemic
Hyperemia: The Consequences of Endothelial
Dysfunction
Nader Dakak, Syed S, Husain, Neil P. Andrews, David Mulcahy, Julio A. Panza,
Arshed A. Quyyumi. National Institutes of Health, Bethesda, MD
Post-ischemic vasodilation during reactive hyperemia is believed to be pri-
marily due to accumulation of ischemic metabolites. To investigate the con-
tribution of nitric oxide (NOI release from vascular endothelium to reactive
hyperemia in humans, we studied the effect of inhibition of NO synthesis
using L-NG monomethyl arginine (L-NMMA) in 40 pts, 22 with, and 18 with-
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High dose NO (16 ~mol/min) caused an increase in endocardial and to-
tal myocardial blood flow which was similar to that produced by acetyl-
choline.Conclusions: Nitric oxide causes dose dependent increases in my-
ocardial blood flow and the endocardial to epicardial blood flow ratio. High
dose endoluminal NO infusion causes changes in myocardial blood flow and
transmural myocardial perfusion which are equivalent to that caused byen-
dothelial derived NO, Moreover, whether administered exogenously or re-
leased endogenously, NO is a preferential sub-endocardial vasodilator.
The effects of nitric oxide (NO) on myocardial blood flow (MBFI have been
studied previously by observing responses to agents that stimulate or block
endogenous NO release. To study the direct in vivo effects of endoluminally
administered NO on transmural myocardial perfusion, we studied 4 anes-
thetized dogs using a new method for intracoronary NO administration. NO
gas was bubbled through deoxygenated saline to achieve the saturation con-
stant (2-3 mM), During ventricular pacing at 100 beats/min, the solution was
infused into the left main coronary artery at doses of 0.2 and 16 ~mol/min,
Transmural myocardial perfusion and coronary blood flow were measured
with radioactive microspheres after 2 minutes of infusion. Changes in MFB
(ml/gm/min) induced from continuous NO infusion were compared to en-
dothelially mediated NO release induced by intracoronary administration of
acetylcholine (Ach 2,0 ~mollmin) and non-NO mediated vasodilitation by in-
tracoronary adenosine (AD 1.2 ~mol/min).
Results:
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Paradoxical vasoconstriction of stenotic coronary arteries has been reported
during dynamic exercise (Ex) in patients with coronary artery disease (CADI.
Thus, 19 patients with CAD were studied at rest (R), during 2 levels of supine
bicycle Ex, and after 1,6 mg sUblingual nitroglycerin. The cross-sectional area
(CSAI of a normal and a stenotic vessel was determined by biplane quanti-
tative coronary arteriography. Seven patients were given 2 mg intracoronary
phentolamine (PHE) prior to Ex, whereas 12 patients without pretreatment
served as controls (C). Workload was 81 ± 34 watts in C and 92 ± 18 watts
in PHE Ins). Mean aortic pressure during Ex was 107 ± 19 mmHg in C and
123 ± 16 mmHg in PHE (ns).
Percent changes in CSA were as follows:
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Conclusions: Exercise-induced vasoconstriction of stenotic coronary arter-
ies is prevented by intracoronary administration of phentolamine. This obser-
vation suggests that exercise-induced vasoconstriction is mediated, at least
in part, by alpha-adrenergic mechanisms.
Alpha-Adrenergic Mechanisms in Exercise-
induced Vasoconstriction of Stenotic Coronary
Arteries
Substance P (SP) may be a more useful endothelium-dependent vasodila-
tor in studying coronary vascular function in atherosclerosis, because unlike
acetylcholine (ACH). SP has no direct smooth muscle constricting effects.
Because dilation has been reported with SP in pts with constriction with
ACH, we investigated whether SP causes dilation by releasing nitric oxide
(NO) from the human coronary vasculature. The effect of L-NMMA (L-NG
Investigation of Nitric Oxide Release from Human
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